February 2027
CFP closes 29 Jan
International Conference on CRISPR Technologies and Agricultural/Medical Applications
ICCTAMA 2027
International Conference on CRISPR Technologies and Agricultural/Medical Applications is a one-day event in Beijing, China on 25 February 2027, organized by Biofora Worldwide. Abstracts are due by 29 January 2027. Biofora Worldwide has 77 other upcoming conferences listed here.
Important dates
-
Abstract / full paper deadline
In 74 days
-
Conference
Beijing, China
All deadlines are as published by the organizer. Check the official website for the time zone.
About this conference
Scholars and industry leaders will gather to explore CRISPR technologies and their applications in both agriculture and medicine. The conference will feature a series of academic presentations, workshops, and panel discussions on topics such as genetic modifications in crops, gene therapies, and regulatory challenges. Participants are invited to submit their research findings, case studies, or practical applications in various presentation formats. The event aims to encourage dialogue and collaboration among experts, providing opportunities for networking and exchange of ideas. Attendees will gain valuable information to inform their future research and practices within the context of rapid advancements in CRISPR technologies.
Call for papers
Abstracts are due by 29 January 2027. Submission details are on the official website.
Where this information comes from
- Source
- Submitted by the organizer
- Listed on
- 26 October 2026
- Verification
- Reviewed by an editor before publishing
- Reference
- FCA2917999
Questions about ICCTAMA 2027
When and where is ICCTAMA 2027?
25 February 2027 in Beijing, China.
Can I attend online?
This listing does not confirm an online option. Check the official website.
What is the submission deadline?
Abstracts are due by 29 January 2027.
How do I register?
Registration and fees are handled by the organizer on the official website.
Verify that you represent this event.
Tell us what needs to be reviewed.